Healthcare provider profile · identity verified

Teresa E Grant, MD

Internal Medicine · SANDWICH, IL · NPI 1922091412

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	358	96
Amlodipine Besylate	Amlodipine Besylate	279	77
Levothyroxine Sodium	Levothyroxine Sodium	276	64
Lisinopril	Lisinopril	271	73
Simvastatin	Simvastatin	268	86
Metoprolol Succinate	Metoprolol Succinate	228	60
Omeprazole	Omeprazole	190	55
Losartan Potassium	Losartan Potassium	158	52
Glimepiride	Glimepiride	141	40
Tramadol Hcl	Tramadol Hcl	135	34
Gabapentin	Gabapentin	114	38
Montelukast Sodium	Montelukast Sodium	114	31
Metformin Hcl	Metformin Hcl	113	33
Furosemide	Furosemide	106	35
Warfarin Sodium	Warfarin Sodium	102	22
Alprazolam	Alprazolam	98	37
Metoprolol Tartrate	Metoprolol Tartrate	96	29
Metformin Hcl Er	Metformin Hcl	95	33
Pantoprazole Sodium	Pantoprazole Sodium	89	27
Meloxicam	Meloxicam	87	34
Prednisone	Prednisone	81	52
Escitalopram Oxalate	Escitalopram Oxalate	78	23
Rosuvastatin Calcium	Rosuvastatin Calcium	77	25
Ozempic	Semaglutide	75	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	24
Pravastatin Sodium	Pravastatin Sodium	73	16
Diclofenac Sodium	Diclofenac Sodium	67	23
Fluticasone Propionate	Fluticasone Propionate	60	23
Allopurinol	Allopurinol	59	17
Duloxetine Hcl	Duloxetine Hcl	59	23
Sertraline Hcl	Sertraline Hcl	58	21
Potassium Chloride	Potassium Chloride	57	18
Alendronate Sodium	Alendronate Sodium	55	12
Citalopram Hbr	Citalopram Hydrobromide	54	16
Albuterol Sulfate Hfa	Albuterol Sulfate	52	24
Clonazepam	Clonazepam	52	13
Clopidogrel	Clopidogrel Bisulfate	52	16
Trazodone Hcl	Trazodone Hcl	50	22
Zolpidem Tartrate	Zolpidem Tartrate	48	13
Atenolol	Atenolol	46	12
Hydrochlorothiazide	Hydrochlorothiazide	46	17
Carvedilol	Carvedilol	43	17
Famotidine	Famotidine	43	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	12
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	35	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	17
Ibandronate Sodium	Ibandronate Sodium	35	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	31	13
Vitamin D2	Ergocalciferol (Vitamin D2)	30	14
Triamcinolone Acetonide	Triamcinolone Acetonide	29	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Fluconazole	Fluconazole	27	18
Buspirone Hcl	Buspirone Hcl	26	11
Lovastatin	Lovastatin	25	suppressed
Acyclovir	Acyclovir	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	22
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	19
Cephalexin	Cephalexin	23	18
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Baclofen	Baclofen	22	suppressed
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Bumetanide	Bumetanide	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	14
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Amoxicillin	Amoxicillin	16	13
Flecainide Acetate	Flecainide Acetate	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Indomethacin	Indomethacin	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Nystop	Nystatin	14	suppressed
Azithromycin	Azithromycin	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Eliquis	Apixaban	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Levofloxacin	Levofloxacin	13	12
Topiramate	Topiramate	13	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Risperidone	Risperidone	12	suppressed
Valsartan	Valsartan	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Glipizide	Glipizide	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Sulfasalazine	Sulfasalazine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error